Antibody complexes and methods for immunolabeling
View Patent ↗The present invention provides labeling reagents and methods for labeling primary antibodies and for detecting a target in a sample using an immuno-labeled complex that comprises a target-binding antibody and one or more labeling reagents. The labeling reagents comprise monovalent antibody fragments or non-antibody monomeric proteins whereby the labeling proteins have affinity for a specific region of the target-binding antibody and are covalently attached to a label. Typically, the labeling reagent is an anti-Fc Fab or Fab′ fragment that was generated by immunizing a goat or rabbit with the Fc fragment of an antibody. The present invention provides for discrete subsets of labeling reagent and immuno-labeled complexes that facilitate the simultaneous detection of multiple targets in a sample wherein the immuno-labeled complexes are distinguished by i) a ratio of label to labeling reagent, or ii) a physical property of said label, or iii) a ratio of labeling reagent to said target-binding antibody, or iv) by said target-binding antibody. This is particularly useful for fluorophore labels that can be attached to labeling reagents and subsequently immuno-labeled complexes in ratios for the detection of multiple targets.
1. A method of forming a non-covalent immuno-labeled complex, wherein said method comprises the steps of:
a) contacting in a reaction vessel a solution of target-binding antibodies with a discreet labeling reagent subset to form a labeling mixture, wherein said labeling reagent subset is distinguished by i) ratio of label to labeling reagent or ii) a physical properties of said label, wherein said target-binding antibody comprises an Fc region, wherein said labeling reagent is a monovalent antibody fragment having affinity for said Fc region and wherein said monovalent antibody fragment is independently covalently linked to one or more labels at a region other than the Fc-binding region of said monovalent antibody fragment;
b) incubating said labeling mixture for a time period sufficient for one or more labeling reagents to form a non-covalent complex with a target-binding antibody, wherein said Fc region of said target binding antibody is selectively bound by labeling reagent;
c) removing unbound labeling reagent from the labeling mixture by adding to the reaction vessel a capture reagent comprising immunoglobulin proteins or fragments thereof to form the non-covalent immuno-labeled complex subset, wherein the capture reagent is capable of binding to the labeling reagent that does not bind to the target binding antibody; and,
d) optionally repeating said steps a), b), and c) to form a panel of non-covalent immuno-labeled complex subsets wherein each subset is distinguished from another subset by i) a ratio of label to labeling reagent, or ii) a physical property of said label, or iii) a ratio of labeling reagent to said target-binding antibody, or iv) by said target-binding antibody.
2. The method according to claim 1 , wherein said target binding antibody is a murine monoclonal antibody, a rabbit polyclonal antibody or a goat polyclonal antibody.
3. The method according to claim 2 , wherein said target-binding antibodies are in a solution comprising serum proteins or ascites proteins.
4. The method according to claim 1 , wherein said labeling reagent is a Fab or Fab' fragment.
5. The method according to claim 4 , wherein said label is selected from the group consisting of a chromophore, a fluorophore, a fluorescent protein, a phosphorescent dye, a tandem dye, a particle, a hapten, an enzyme and a radioisotope.
6. The method according to claim 5 , wherein said fluorophore is selected from the group consisting of a coumarin, a xanthene, a cyanine, a pyrene, a borapolyazaindacene, an oxazine, and derivatives thereof.
7. The method according to claim 5 , wherein said fluorescent protein is a phycobiliprotein.
8. The method according to claim 5 , wherein said tandem dye is selected from the group consisting of a cyanine-phycobiliprotein derivative and xanthene-phycobiliprotein derivative.
9. The method according to claim 5 , wherein said enzyme is selected from the group consisting of a peroxidase, a phosphatase, a glycosidase, and a luciferase.
10. A non-covalent immuno-labeled complex generated by a process comprising:
a) contacting in a reaction vessel a solution of target-binding antibodies with a labeling reagent subset to form a labeling mixture, wherein said labeling reagent subset is distinguished from another labeling reagent subset by i) ratio of label to labeling reagent or ii) a physical properties of said label, wherein said target-binding antibody comprises an Fc region, wherein said labeling reagent is a monovalent antibody fragment having affinity for said Fc region and wherein said monovalent antibody fragment is independently covalently linked to one or more labels at a region other than the Fc-binding region of said monovalent antibody fragment;
b) incubating said labeling mixture for a time period sufficient for one or more labeling reagents to form a non-covalent complex with a target-binding antibody, wherein said Fc region of said target binding antibody is selectively bound by labeling reagent; and,
c) removing unbound labeling reagent from the labeling mixture by adding to the reaction vessel a capture reagent comprising immunoglobulin proteins or fragments thereof to bind the labeling reagent that does not bind to the target-binding antibody whereby to form the non-covalent immuno-labeled complex.
11. The immuno-labeled complex according to claim 10 , wherein said process further comprises repeating said steps a), b), and c) to form subsets of immuno-labeled complexes wherein each subset is distinguished from another subset by i) ratio of label to labeling reagent or ii) a physical properties of said label, or iii) a ratio of labeling reagent to said target-binding antibody or iv) by said target-binding antibody.
12. The immuno-labeled complex according to claim 10 , wherein said target-binding antibody is a murine monoclonal antibody, a rabbit polyclonal antibody or a goat polyclonal antibody.
13. The immuno-labeled complex according to claim 12 , wherein said labeling reagent is a Fab or Fab' fragment.
14. The immuno-labeled complex according to claim 13 , wherein said label is selected from the group consisting of a chromophore, a fluorophore, a fluorescent protein, a phosphorescent dye, a tandem dye, a particle, a hapten, an enzyme and a radioisotope.
15. The immuno-labeled complex according to claim 14 , wherein said fluorophore is selected from the group consisting of a coumarin, a xanthene, a cyanine, a pyrene, a borapolyazaindacene, an oxazine, and derivatives thereof.